Outcomes of unrelated cord blood transplantation in pediatric recipients

Bone Marrow Transplantation

Volumn 34, Issue 2, 2004, Pages 129-136

  Styczynski, J ^a,b   Cheung, Y K ^c   Garvin, J ^a   Savage, D G ^c   Billote, G B ^a   Harrison, L ^a   Skerrett, D ^c   Wolownik, K ^a   Wischhover, C ^a   Hawks, R ^a   Bradley, M B ^a   Del Toro, G ^a   George, D ^a   Yamashiro, D ^a   van de Ven, C ^a   Cairo, M S ^a  

^a Children's Hosp of NY Presbyterian   (United States)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Ablative conditioning; CD34 cell dose; GVHD; Non TBI conditioning; UCBT

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; BUSULFAN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUCONAZOLE; FOSCARNET; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLIN G; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; BETA THALASSEMIA; CANCER CHEMOTHERAPY; CHILD; CHRONIC DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; FANCONI ANEMIA; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GLOBOID CELL LEUKODYSTROPHY; GRAFT VERSUS HOST REACTION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HERPES SIMPLEX; HLA MATCHING; HODGKIN DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFANT; LYMPHOCYTE COUNT; MALE; MULTIVARIATE ANALYSIS; MYCOSIS; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; PEDIATRICS; PRIORITY JOURNAL; PROBABILITY; RECIPIENT; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; WHOLE BODY RADIATION; WISKOTT ALDRICH SYNDROME;

ADOLESCENT; ADULT; ANTIGENS, CD34; BLOOD DONORS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HUMANS; INFANT; MALE; PROBABILITY; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 20844444615     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704537     Document Type: Article

References (28)

1. Wagner JE, Rosenthal J, Sweetman R et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996; 88: 795-802.
2. Wagner JE, Barker JN, DeFor TE et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611-1618.
3. Kurtzberg J, Laughlin M, Graham ML et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335: 157-166.
4. Cairo MS, Wagner JE. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 1997; 90: 4665-4678.
5. Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337: 373-381.
6. Rocha V, Wagner Jr JE, Sobocinski KA et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000; 342: 1846-1854.
7. Sanz MA, Sanz GF. Unrelated donor umbilical cord blood transplantation in adults. Leukemia 2002; 16: 1984-1991.
8. Wernet P, Lopez J, Contreras M et al. The International NETCORD Organization for High Standard Cord Blood Banking. Blood 2002; 100: 468b (abstract 5450).
9. Lansdorp PM, Dragowska W, Mayani H et al. Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood 1994; 84: 36-43.
10. Vaziri H, Dragowska W, Allsopp RC et al. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994; 91: 9857-9860.
11. Ohnuma K, Isoyama K, Nishihira H et al. Cord blood transplantation from HLA-mismatched unrelated donors. Leukemia Lymphoma 2002; 43: 1029-1034.
12. Gluckman E, Locatelli F. Umbilical cord blood transplants. Exp Hematol 2000; 28: 1197-1205.
13. Plunkett W, Rodriguez Jr CO, Nowak BJ et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors [comment]. J Clin Oncol 1998; 16: 3607-3615.
14. Dupont B, Yang SY. Histocompatibility. In: Forman SJBK, Thomas ED (ed.). Bone Marrow Transplantation. Blackwell Scientific: Cambridge, MA, 1994, 22-40.
15. Petersdorf EW, Smith AG, Haase AM et al. Polymorphism of HLA-DRw52-associated DRB1 genes as defined by sequence-specific oligonucleotide probe hybridization and sequencing. Tissue Antigens 1991; 38: 169-177.
16. Bessmertny O, Harrison L, Osunkwo I et al. Significant alteration of mycophenolate mofetil pharmacokinetics in pediatric allogeneic stem cell transplant (alloSCT) recipients: alternate dosing is required in alloSCTs vs solid organ allograft recipients. Blood 2002; 100: 4188 (abstract).
17. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
18. Rubinstein P, Dobrila L, Rosenfield RE et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995; 92: 10119-10122.
19. Fraser JK, Cairo MS, Wagner EL et al. Cord blood transplantation study (COBLT): cord blood bank standard operating procedures [comment]. J Hematother 1998; 7: 521-561.
20. Osunkwo I, Cooney E, Bessmertny O et al. Liposomal amphotericin B (AMB) prophylaxis is safe and effective in preventing invasive fungal infections (IFI) in related and unrelated allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2003; 9: 34 (abstract).
21. Shereck E, Bessmertny O, Cairo MS et al. Cytomegalovirus (CMV) prophylaxis with alternate day gancyclovir/foscarnet in at risk pediatric allogeneic stem cell transplant (AlloSCT) recipients is 100% effective in preventing CMV infections and reducing gancyclovir hematopoietic toxicity. Blood 2002; 100: 627a (abstract).
22. Collett D. Modelling Survival Data in Medical Research, 1st edn. Chapman & Hall: London, New York, 1994, 40-44.
23. Laughlin MJ, Barker J, Bambach B et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815-1822.
24. Thomson BG, Robertson KA, Gowan D et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 2000; 96: 2703-2711.
25. McGlave PB, DeFor TE, Miller JS et al. Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program. Bone Marrow Transplant 2000; 26: 723-728.
26. Hansen JA, Gooley TA, Martin PJ et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 1998; 338: 962-968.
27. Schiller G, Feig SA, Territo M et al. Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors. Br J Haematol 1994; 88: 72-78.
28. Barker JN, Weisdorf DJ, DeFor TE et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003; 102: 1915-1919.